AIMI Financial Statements

Balance sheet, income statement, cash flow, and dividends for Aim Immunotech Inc (AIMI).


$12.61M Market Cap.

As of 03/27/2025 5:00 PM ET (MRY) • Disclaimer

AIMI Market Cap. (MRY)


AIMI Shares Outstanding (MRY)


AIMI Assets (MRY)


Total Assets

$8.61M

Total Liabilities

$9.93M

Total Investments

$2.28M

AIMI Income (MRY)


Revenue

$170.00K

Net Income

-$17.32M

Operating Expense

$19.91M

AIMI Cash Flow (MRY)


CF Operations

-$14.89M

CF Investing

$4.71M

CF Financing

$6.44M

AIMI Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

AIMI Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$8,608,000 (-55.59%)

$19,381,000 (-52.13%)

$40,488,000 (-29.83%)

$57,699,000 (-10.66%)

Assets Current

$4,176,000 (-71.31%)

$14,556,000 (-59.92%)

$36,321,000 (-27.67%)

$50,213,000 (24.57%)

Assets Non-Current

$4,432,000 (-8.15%)

$4,825,000 (15.79%)

$4,167,000 (-44.34%)

$7,486,000 (-69.16%)

Goodwill & Intangible Assets

$2,594,000 (12.15%)

$2,313,000 (19.17%)

$1,941,000 (-1.67%)

$1,974,000 (31.78%)

Shareholders Equity

-$1,322,000 (-112.92%)

$10,234,000 (-73.40%)

$38,468,000 (-32.37%)

$56,879,000 (-7.20%)

Property Plant & Equipment Net

$726,000 (-11.89%)

$824,000 (-19.53%)

$1,024,000 (-75.60%)

$4,196,000 (-36.92%)

Cash & Equivalents

$1,701,000 (-68.73%)

$5,439,000 (-79.90%)

$27,053,000 (-15.70%)

$32,093,000 (-16.64%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$2,276,000 (-70.17%)

$7,631,000 (6.92%)

$7,137,000 (-55.88%)

$16,175,000 (1.88%)

Investments Current

$2,276,000 (-70.17%)

$7,631,000 (6.92%)

$7,137,000 (-55.88%)

$16,175,000 (3128.54%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$6,383,000 (-0.93%)

$6,443,000 (1609.02%)

$377,000 (90.40%)

$198,000 (-48.30%)

Accumulated Retained Earnings (Deficit)

-$426,828,000 (-4.23%)

-$409,508,000 (-7.61%)

-$380,546,000 (-5.38%)

-$361,101,000 (-5.59%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$2,941,000 (309.61%)

$718,000 (-14.22%)

$837,000 (461.74%)

$149,000 (-93.48%)

Debt Current

$2,546,000 (1041.70%)

$223,000 (25.28%)

$178,000 (381.08%)

$37,000 (-86.64%)

Debt Non-Current

$395,000 (-20.20%)

$495,000 (-24.89%)

$659,000 (488.39%)

$112,000 (-94.42%)

Total Liabilities

$9,930,000 (8.56%)

$9,147,000 (352.82%)

$2,020,000 (146.34%)

$820,000 (-75.08%)

Liabilities Current

$9,535,000 (10.21%)

$8,652,000 (535.71%)

$1,361,000 (102.23%)

$673,000 (-38.93%)

Liabilities Non-Current

$395,000 (-20.20%)

$495,000 (-24.89%)

$659,000 (348.30%)

$147,000 (-93.28%)

AIMI Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$170,000 (-15.84%)

$202,000 (43.26%)

$141,000 (4.44%)

$135,000 (-17.18%)

Cost of Revenue

$31,000 (-26.19%)

$42,000 (0%)

$0 (0%)

$850,000 (5.46%)

Selling General & Administrative Expense

$13,714,000 (-35.12%)

$21,137,000 (61.67%)

$13,074,000 (50.76%)

$8,672,000 (0.21%)

Research & Development Expense

$6,197,000 (-43.35%)

$10,939,000 (56.49%)

$6,990,000 (-8.89%)

$7,672,000 (34.13%)

Operating Expenses

$19,911,000 (-37.89%)

$32,058,000 (59.80%)

$20,061,000 (12.03%)

$17,907,000 (23.42%)

Interest Expense

$585,000 (0%)

$0 (0%)

$0 (0%)

$67,000 (-90.03%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$17,320,000 (40.20%)

-$28,962,000 (-48.94%)

-$19,445,000 (-1.66%)

-$19,127,000 (-32.83%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$17,320,000 (40.20%)

-$28,962,000 (-48.94%)

-$19,445,000 (-1.66%)

-$19,127,000 (-32.83%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$17,320,000 (40.20%)

-$28,962,000 (-48.94%)

-$19,445,000 (-1.66%)

-$19,127,000 (-32.83%)

Weighted Average Shares

$56,016,870 (15.30%)

$48,585,404 (1.12%)

$48,047,288 (1.49%)

$47,339,975 (48.67%)

Weighted Average Shares Diluted

$56,016,870 (15.30%)

$48,585,404 (1.12%)

$48,047,288 (1.49%)

$47,339,975 (48.67%)

Earning Before Interest & Taxes (EBIT)

-$16,735,000 (42.22%)

-$28,962,000 (-48.94%)

-$19,445,000 (-2.02%)

-$19,060,000 (-38.84%)

Gross Profit

$139,000 (-13.13%)

$160,000 (13.48%)

$141,000 (119.72%)

-$715,000 (-11.20%)

Operating Income

-$19,772,000 (38.01%)

-$31,898,000 (-60.13%)

-$19,920,000 (-6.97%)

-$18,622,000 (-22.90%)

AIMI Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$4,706,000 (665.63%)

-$832,000 (-107.57%)

$10,988,000 (1841.36%)

-$631,000 (93.11%)

Net Cash Flow from Financing

$6,444,000 (1228.66%)

$485,000 (506.25%)

$80,000 (-99.02%)

$8,188,000 (-85.52%)

Net Cash Flow from Operations

-$14,888,000 (29.99%)

-$21,267,000 (-32.03%)

-$16,108,000 (-15.35%)

-$13,965,000 (-34.69%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,738,000 (82.71%)

-$21,614,000 (-328.85%)

-$5,040,000 (21.35%)

-$6,408,000 (-117.30%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$5,262,000 (1889.80%)

-$294,000 (-104.00%)

$7,359,000 (3128.40%)

-$243,000 (97.16%)

Capital Expenditure

-$18,000 (-138.30%)

$47,000 (-98.77%)

$3,814,000 (1769.61%)

$204,000 (1027.27%)

Issuance (Repayment) of Debt Securities

$2,249,000 (0%)

$0 (0%)

$0 (0%)

-$4,854,000 (-3.61%)

Issuance (Purchase) of Equity Shares

$4,195,000 (764.95%)

$485,000 (506.25%)

$80,000 (-99.39%)

$13,042,000 (-78.71%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$686,000 (182.30%)

$243,000 (-74.53%)

$954,000 (-39.16%)

$1,568,000 (51.35%)

Depreciation Amortization & Accretion

$550,000 (4.76%)

$525,000 (105.08%)

$256,000 (-66.97%)

$775,000 (5.73%)

AIMI Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

81.80% (3.28%)

79.20% (-20.80%)

100.00% (118.88%)

-529.60% (-34.25%)

Profit Margin

-10188.20% (28.94%)

-14337.60% (-3.96%)

-13790.80% (2.66%)

-14168.10% (-60.37%)

EBITDA Margin

-9520.60% (32.37%)

-14077.70% (-3.44%)

-13609.20% (-0.48%)

-13544.40% (-69.89%)

Return on Average Equity (ROAE)

-553.40% (-367.79%)

-118.30% (-179.01%)

-42.40% (-41.33%)

-30.00% (-6.38%)

Return on Average Assets (ROAA)

-128.10% (-30.85%)

-97.90% (-141.13%)

-40.60% (-39.04%)

-29.20% (-12.31%)

Return on Sales (ROS)

-9844.10% (31.34%)

-14337.60% (-3.96%)

-13790.80% (2.32%)

-14118.50% (-67.64%)

Return on Invested Capital (ROIC)

-712.00% (-82.99%)

-389.10% (-200.00%)

-129.70% (-60.32%)

-80.90% (-28.82%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.64 (12.82%)

-0.73 (6.03%)

-0.78 (66.09%)

-2.3 (42.18%)

Price to Sales Ratio (P/S)

65.24 (-38.34%)

105.81 (-0.45%)

106.28 (-67.06%)

322.61 (-7.74%)

Price to Book Ratio (P/B)

-9.54 (-554.60%)

2.1 (438.21%)

0.39 (-49.61%)

0.77 (-34.85%)

Debt to Equity Ratio (D/E)

-7.51 (-940.16%)

0.89 (1586.79%)

0.05 (278.57%)

0.01 (-74.07%)

Earnings Per Share (EPS)

-0.31 (48.33%)

-0.6 (-50.00%)

-0.4 (0.00%)

-0.4 (11.11%)

Sales Per Share (SPS)

0 (-25.00%)

0 (33.33%)

0 (0.00%)

0 (-40.00%)

Free Cash Flow Per Share (FCFPS)

-0.27 (39.13%)

-0.44 (-70.70%)

-0.26 (12.03%)

-0.29 (10.74%)

Book Value Per Share (BVPS)

-0.02 (-111.37%)

0.21 (-73.66%)

0.8 (-33.36%)

1.2 (-37.56%)

Tangible Assets Book Value Per Share (TABVPS)

0.11 (-69.52%)

0.35 (-56.23%)

0.8 (-31.86%)

1.18 (-40.59%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0%)

0 (0%)

1 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.93 (-280.82%)

-0.24 (-133.84%)

0.72 (294.10%)

-0.37 (86.79%)

Asset Turnover

0.01 (85.71%)

0.01 (133.33%)

0 (50.00%)

0 (-33.33%)

Current Ratio

0.44 (-73.96%)

1.68 (-93.70%)

26.69 (-64.23%)

74.61 (103.97%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$14,906,000 (29.75%)

-$21,220,000 (-72.60%)

-$12,294,000 (10.66%)

-$13,761,000 (-32.44%)

Enterprise Value (EV)

$15,099,876 (116.60%)

$6,971,444 (150.17%)

-$13,896,138 (-303.88%)

$6,815,732 (-81.42%)

Earnings Before Tax (EBT)

-$17,320,000 (40.20%)

-$28,962,000 (-48.94%)

-$19,445,000 (-1.66%)

-$19,127,000 (-32.83%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$16,185,000 (43.08%)

-$28,437,000 (-48.19%)

-$19,189,000 (-4.94%)

-$18,285,000 (-40.71%)

Invested Capital

-$2,281,000 (-161.73%)

$3,695,000 (-66.32%)

$10,970,000 (-52.53%)

$23,108,000 (-10.32%)

Working Capital

-$5,359,000 (-190.77%)

$5,904,000 (-83.11%)

$34,960,000 (-29.43%)

$49,540,000 (26.35%)

Tangible Asset Value

$6,014,000 (-64.76%)

$17,068,000 (-55.72%)

$38,547,000 (-30.83%)

$55,725,000 (-11.67%)

Market Capitalization

$12,613,876 (-41.29%)

$21,485,444 (43.27%)

$14,996,862 (-65.93%)

$44,020,732 (-39.56%)

Average Equity

$3,129,500 (-87.22%)

$24,490,000 (-46.54%)

$45,811,000 (-28.26%)

$63,856,250 (24.90%)

Average Assets

$13,525,000 (-54.28%)

$29,580,250 (-38.31%)

$47,953,000 (-26.67%)

$65,397,500 (18.22%)

Invested Capital Average

$2,350,500 (-68.43%)

$7,444,250 (-50.33%)

$14,987,750 (-36.37%)

$23,553,750 (7.79%)

Shares

63,706,446 (30.43%)

48,841,656 (1.58%)

48,082,275 (0.49%)

47,848,622 (17.60%)